Research Article
Actin-Binding LIM 1 (ABLIM1) Inhibits Glioblastoma Progression and Serves as a Novel Prognostic Biomarker
Figure 2
Cancer-specific survival (CSS) of GBM patients. CSS of the enrolled GBM cohort () was analyzed using the Kaplan-Meier method according to patients’ ABLIM1 level (a), age (b), sex (c), tumor size (d), surgery (e), and chemotherapy (f). by log-rank test.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |